WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma, IDH-Wildtype · MGMT-Unmethylated Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Northwestern University, Chicago, Illinois, United States
Contact: Study coordinator (Amy Heimberger) · amy.heimberger@northwestern.edu · 312-503-3805
Contact: Principal Investigator (Amy Heimberger)
Northwestern Medicine: Warrenville, Warrenville, Illinois, United States

Study leads

Amy Heimberger
Principal Investigator
Northwestern University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Anaplastic Astrocytoma, IDH-Wildtype · Anaplastic Oligoastrocytoma · Anaplastic Oligodendroglioma

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma

Glioblastoma

Abroad (travel likely)RecruitingPHASE2

Augsburg, Germany · Cologne, Germany

Glutamate Inhibitors in Glioblastoma

Glioblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Zurich, Switzerland

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Glioblastoma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Birmingham, United States · La Jolla, United States